Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | XIAP | P98170 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.44 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29843187 | 1.00 | RAB9A (0.53) | RAB9ANPC1XIAPMAPTSMN1; SMN2 | |
| SCHEMBL4139521 | 0.98 | RAB9A (0.51) | RAB9ANPC1XIAPMAPTSMN1; SMN2 | |
| Iodomethane SCHEMBL9193628 | 0.96 | RAB9A (0.50) | RAB9ANPC1XIAPMAPTSMN1; SMN2 | |
| SCHEMBL9300730 | 0.91 | RAB9A (0.57) | RAB9ANPC1XIAPMAPTSMN1; SMN2 | |
| SCHEMBL26217317 | 0.87 | RAB9A (0.46) | RAB9ANPC1XIAPMAPTSMN1; SMN2 | |
| SCHEMBL8408656 | 0.82 | RAB9A (0.45) | RAB9ANPC1XIAPMAPTSMN1; SMN2 | |
| SCHEMBL17281460 | 0.81 | NPC1 (0.72) | RAB9ANPC1MAPTSMN1; SMN2LMNA | |
| SCHEMBL9301190 | 0.80 | XIAP (0.48) | RAB9ANPC1XIAPMAPTSMN1; SMN2 | |
| SCHEMBL20669005 | 0.79 | NPC1 (0.70) | RAB9ANPC1MAPTSMN1; SMN2LMNA | |
| SCHEMBL12930243 | 0.79 | NPC1 (0.57) | RAB9ANPC1MAPTSMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106701063-B | A kind of controllable organic solid-state luminescent material, preparation method and applications | 三峡大学 | 2019-05-14 | — | — | CN | claimed |
| CN-106701063-A | Controllable organic solid-state luminescent material as well as preparation method and application of controllable organic solid-state luminescent material | 三峡大学 | 2017-05-24 | — | — | CN | claimed |
| US-20170056376-A1 | SELECTIVE ACTIVATORS OF THE INTERMEDIATE CONDUCTANCE CA2+ACTIVATED K+ CHANNEL KCa3.1 AND THEIR METHODS OF USE | UNIV CALIFORNIA (US) | 2017-03-02 | — | — | US | claimed |
| WO-2015164816-A2 | SELECTIVE ACTIVATORS OF THE INTERMEDIATE CONDUCTANCE CA2+-ACTIVATED K+ CHANNEL KCA3.1 AND THEIR METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-10-29 | — | — | WO | claimed |
| EP-1087952-B1 | BENZAZOLE COMPOUNDS AND THEIR USE | NOVARTIS AG (CH) | 2004-06-02 | — | — | EP | claimed |
| US-6410578-B1 | INSECTICIDE, MITICIES, PESTICIDE | NOVARTIS ANIMAL HEALTH US, INC. | 2002-06-25 | — | — | US | claimed |
| CN-1302293-A | Benzazole compounds and their use | NOVARTIS AG (CH) | 2001-07-04 | — | — | CN | claimed |
| EP-1087952-A1 | BENZAZOLE COMPOUNDS AND THEIR USE | Novartis AG (CH) | 2001-04-04 | — | — | EP | claimed |
| WO-1999065886-A1 | BENZAZOLE COMPOUNDS AND THEIR USE | NOVARTIS AG (CH) | 1999-12-23 | — | — | WO | claimed |
| US-4124386-A | Color diffusion transfer receiving layer comprising polymeric quaternary n-heterocyclic mordant | FUJI PHOTO FILM CO., LTD. (JP) | 1978-11-07 | — | — | US | claimed |
| US-3943142-A | Dye intermediates and their preparation and use in the synthesis of methine dyes | EASTMAN KODAK COMPANY (US) | 1976-03-09 | — | — | US | claimed |
| JP-7118248-A | — | — | None | — | — | JP | disclosed |
| JP-6220028-A | — | — | None | — | — | JP | disclosed |
| US-12629356-B2 | Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof | IOVANCE BIOTHERAPEUTICS, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| EP-3565586-B1 | EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF | IOVANCE BIOTHERAPEUTICS INC (US) | 2025-10-08 | — | — | EP | disclosed |
| US-4290870-A | 5-ISOXOLONE, AROMATIC CARBONYL, DIALKYLAMINO AROMATIC CARBONYL OR | FUJI PHOTO FILM CO., LTD. (JP) | 1981-09-22 | — | — | US | disclosed |
| EP-0034279-A2 | Sulfoalkylating agents, process for their preparation and their use in the manufacture of quanternary sulfoalkyl salts | Agfa-Gevaert AG (DE) | 1981-08-26 | — | — | EP | disclosed |
| US-4124386-A | Color diffusion transfer receiving layer comprising polymeric quaternary n-heterocyclic mordant | FUJI PHOTO FILM CO., LTD. (JP) | 1978-11-07 | — | — | US | disclosed |
| US-3961952-A | ELECTROPHOTOGRAPHY, SUPPORTS, COATINGS | ITEK CORPORATION (US) | 1976-06-08 | — | — | US | disclosed |
| US-3943142-A | Dye intermediates and their preparation and use in the synthesis of methine dyes | EASTMAN KODAK COMPANY (US) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629356-B2 | Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof | PBK, IL2, KCNN3 | RAB9A 4594/4885NPC1 1565/4885XIAP 3730/4885 |
| US-20170056376-A1 | SELECTIVE ACTIVATORS OF THE INTERMEDIATE CONDUCTANCE CA2+ACTIVATED K+ CHANNEL KCa3.1 AND THEIR METHODS OF USE | KCNN3, KCNN1, KCNN2 | RAB9A 3176/4885NPC1 2863/4885XIAP 1470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.